Tagged with biotech
Daily Morning Call
From the Floor: Biotech surges again — #SaxoStrats
The US healthcare reform plan has pushed biotechnology shares up sharply. Volatility in the...
SaxoTV
Quarterly outlook: Marathon bull run
The main Q4 topics for equities include the US presidential election, a potential rate hike in...
SaxoTV
#SaxoStrats: Buying Gilead Sciences ahead of Q4...
Saxo Bank’s Head of Equity Strategy Peter Garnry is looking to buy shares in Gilead Sciences...
SaxoTV
Garnry: Four stocks I’m trading ahead of...
More than 230 companies will be reporting their quarterly earnings this week. Saxo Bank's Peter...
SaxoTV
Berger: How I’m trading the US stock sell-off
It’s been a rough start to the year for many assets including equities, which have seen a...
SaxoTV
Van-Petersen: Key currency crosses to look at...
With so many central banks meeting this week, Saxo's Kay Van-Petersen discusses the currency...
SaxoTV
Garnry: Why no-one is talking about the crash...
Biotechnology stocks have fallen significantly since their July peak. But because of the noise...
SaxoTV
Berger: Biotech ETFs bubbling higher
The massive rally in the biotechnology sector is not over according to Serge Berger, also known...
SaxoTV
Earnings Season: GSK will disappoint but pharma...
Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...
SaxoTV
Berger: NASDAQ biotechnology sector overextended
Serge Berger, who is also known as The Steady Trader, believes the NASDAQ Biotechnology ETF...
SaxoTV
#TechWeek: The NASDAQ can go even higher
The NASDAQ can go even higher says Saxo's Peter Garnry. On Monday the index reached 5,000 for the...
SaxoTV
It's Nasdaq Week - here's Peter Garnry's guide...
It's the largest US stock exchange in terms of volume and market share and the Nasdaq is...